Navigation Links
Conseco Reports Preliminary Fourth Quarter and Year-End Results
Date:3/17/2008

$274.0 $1,250.3

Colonial Penn segment:

Life $31.7 $113.7

Supplemental health 2.5 10.4

Total collected premiums $34.2 $124.1

Other Business in Run-off segment:

Long-term care $74.4 $305.8

Major medical .6 2.3

Total collected premiums $75.0 $308.1

BENEFIT RATIOS ON MAJOR SUPPLEMENTAL HEALTH LINES OF BUSINESS -

Preliminary (see note)

Three months ended Year ended

December 31, December 31,

2007 2007

Bankers Life segment:

Medicare Supplement:

Earned premium $159 million $644 million

Benefit ratio(a) 67.6% 67.2%

PDP and PFFS:

Earned premium $90 million $271 million

Benefit ratio(a) 83.6% 85.1%

Long-Term Care:

Earned premium $156 million $621 million

Benefit ratio(a) 102.3% 102.6%

Interest-adjusted benefit ratio

(a non-GAAP measure)(b) 70.2% 71.4%

Conseco Insurance Group (CIG) segment:

Medicare Supplement:

Earned premium $55 million $231 million

Benefit ratio(a) 66.0% 67.6%

Specified Disease:

Earned premium $89 million $359 million

B
'/>"/>

SOURCE Conseco, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine news :

1. Conseco to Host Follow-Up Long-Term Care Conference Call
2. Barta joins Conseco as Senior Vice President, Financial Planning & Analysis; Barra named Senior Vice President, Internal Audit; Clarke to head Investor Relations
3. Conseco Completes Divestiture of Old Block of Fixed and Equity-Indexed Annuities
4. Conseco Sets Earnings Release Date
5. Conseco Reports Third Quarter Results
6. Conseco to Implement Systems and Operational Solution From Long Term Care Group
7. Tongson Joins Conseco as Senior Vice President, Corporate Actuarial
8. Hacker Joins Conseco as Senior Vice President and Treasurer
9. Conseco Files to Formally Extend Due Date for Annual Report on Form 10-K to March 17 and Reschedules Earnings Release and Investor Call
10. Conseco Declines Partnerships Request for Board Seats; Review of Strategic Alternatives Underway
11. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)...in harmless moles, may be key to diagnosis , ...lanoma produces high levels of a protein called IM..., University of Rochester Medical Center researche...ctors a new way to distinguish melanoma -- the mos...es that look like melanoma. , The study was pub...
(Date:7/23/2008)...wire-USNewswire/ -- The American Heart,Association...Lewis,Achievement Award, the association,s highest...rd was established in 2000, to recognize and honor...dical journalists who have documented,the consider...ase and,stroke. This career achievement award was ...
(Date:7/23/2008)...3 /PRNewswire-USNewswire/ -- The Alameda County,Pl...y 24-26 at the Oakland,Marriott to address the soc...n individuals from low-income and communities of c... and counties will attend. Place Matters,is a nati...and Economic,Studies, Health Policy Institute and ...
(Date:7/23/2008)... Dangerous for Morbidly Obese Women? ,As the o...re consulting plastic surgeons for breast reductio...d been thought to have higher complication rates. ... as safe to perform large-volume breast reductions...tudy title: Breast Reduction: Safe in the Morbidly...
Breaking Medicine News(10 mins):Health News:Protein Gives Doctors New Tool to Detect Melanoma 2Health News:Alameda County Hosts National Initiative to Reduce Health Disparities 2
... come up with a bill seeking direct control over a... centres in the state, State Health Minister Digam...roduce a special bill in the next assembly session...perating in the state. This is to check activities...
...that folic acid supplements can help to prevent ca...//. Published in the July 15, 2006 issue of CANC...oom), a peer-reviewed journal of the American Canc...1 of 43 patients with the precancerous laryngeal l...
...rogrammer flew in to Boston from India, on April 2...ervices company headquartered //in the 18th floor ...ze that a potential measles outbreak loomed before...toms of measles such as rash, fever, cough began t...
...t a new report looked at new prescription- only m...d 2006 //. In the last six years, 78 new prescri...alian PBS, which was the equivalent of Pharmac. O...stered in New Zealand, of which only 20 are funde...
Other Medicine News:Health News:Folic Acid Supplements to Prevent Cancer 2Health News:Global Threat of Measles Outbreak 2
(Date:7/22/2008)...APOLIS, July 22 /- Nonin Medical, a l...ions for more than 20 years, has entered,the clini... to measure,regional oxygen saturation. Today,s mo...ontinuous monitoring of the regional blood oxygena...sting data and outcomes from an ongoing clinical s...
(Date:7/22/2008)...Demonstrates Feasibility and Efficacy of Treating ...er Cancer, SAN FRANCISCO, and YONGIN-SI, South Ko...rancisco, CA and Ottawa, Ontario), and its South,K...hat novel findings from,a Phase I clinical trial o...ted that the product was well-tolerated and result...
(Date:7/22/2008)...offrey Allan Will Stress the Importance to Patient...s Approval Pathway, RICHMOND, Va., July 22 /PRNew...a developer of follow-on biologics and biopharmace...., CEO of Insmed, will present at a,Congressional ...,significant need for establishing an approval pat...
(Date:7/22/2008)...loped and Validated by Columbia University Medical...ietary MicroRNA Technology, The Test Differentia... Cancer (NSCLC), Classifying Squamous-Cell Carcin...ent and Specificity of 90 Percent,This is the Firs...nsitivity as Biomarkers for Accurate Diag...
Breaking Medicine Technology:Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5First Lady Honors Women at International Womens Day Event 13817 1First Lady Honors Women at International Womens Day Event 13817 2Advanced Life Sciences Receives Nasdaq Notification 3796 1Advanced Life Sciences Receives Nasdaq Notification 3796 2Advanced Life Sciences Receives Nasdaq Notification 3796 3Longs Drug Stores Announces Todd Vasos Executive Vice President and Chief Operating Officer 13812 1Longs Drug Stores Announces Todd Vasos Executive Vice President and Chief Operating Officer 13812 2Researchers Design Promising Cancer Drug 13810 1Researchers Design Promising Cancer Drug 13810 2
Tube for Right Bronchus - Ruschelit™ PVC. Color coded for easy identification of ports, balloons and 15mm connectors. High volume/low pressure cuffs. With Carina hook. X-ray opaque line. Gradua
Tube for Left Bronchus - Ruschelit™ PVC. Color coded for easy identification of ports, balloons and 15mm connectors. High volume/low pressure cuffs. With Carina hook. X-ray opaque line. Graduat
Laser resistant tubes for use with CO2 and KTP Lasers., ,Designed for airway management during laser surgery of the larynx or other areas in close proximity to the trachea.
For MicroLaryngeal Tracheal Surgery
Medicine Products: